Effectiveness Clinical Trial
Official title:
Effectiveness of a Telegeriatric Intervention in Older Adults During the Covid-19 Contingency
Verified date | February 2021 |
Source | Universidad Iberoamericana A.C., Mexico |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this studdy is to assess the effectiveness of a telegeriatric intervention
Status | Completed |
Enrollment | 110 |
Est. completion date | November 16, 2020 |
Est. primary completion date | October 20, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years and older |
Eligibility | Inclusion Criteria: - Adults 60 years and over - Who agree to participate in the study. Exclusion Criteria: - Older adults who are in a systematic exercise program or directed food restriction programs - Physical, sensory or cognitive disabilities that prevent exercise, includes Mini Mental State Examination less than 20 points of the total score - Any condition acute or chronic health conditions that clinical staff judge as an impediment to the exercise program or remote monitoring - Recent major or limb surgery - Orthopedic conditions that would impede the exercise program - Any problem swallowing - Previous mental disorders such as disorder and schizophrenia - Not having personal access to the WhatsApp application via video call. |
Country | Name | City | State |
---|---|---|---|
Mexico | Universidad Iberoamericana | Ciudad de Mexico | Ciudad De México |
Lead Sponsor | Collaborator |
---|---|
Universidad Iberoamericana A.C., Mexico |
Mexico,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual analog scale of the European quality of life questionnaire | The visual analog scale of the European quality of life questionnaire, adapted and validated to Spanish, Mexico (EQ5D-VAS) will be used. Which consists of a visual analog scale, its total score ranges from 0 to 100 points, the higher the score, the better the quality of life, it will be considered as a continuous quantitative variable. (Juárez-Cedillo T et al., 2015) Change from baseline to week 12 | Change from baseline to week 12 | |
Primary | Physical performance. | It will be evaluated through the short physical performance test (SPPB), which is a test that includes three dimensions: strength. March and balance, your score ranges from 0 to 12 points, the higher the score the better the physical performance, it will be considered as a continuous quantitative variable. (Guralnik JM et al., 1989) Change from baseline to week 12 | Change from baseline to week 12 | |
Primary | Depressive symptoms | It will be evaluated using the CESD scale 7 items validated into Spanish in Mexico. His score ranges from 0 to 21 points, the higher the score, the greater the depressive symptoms. The total score will be considered as a continuous quantitative variable. (Salinas-Rodríguez A et al., 2014) Change from baseline to week 12 | Change from baseline to week 12 | |
Primary | Symptoms of anxiety. | It will be evaluated through the geriatric anxiety inventory, which is validated in Spanish, consists of 20 dichotomous items, its total score ranges from 0 to 20, the higher the score, the greater the anxiety symptoms. It will be considered as a continuous quantitative variable. (Márquez-González M et al., 2012) Change from baseline to week 12 | Change from baseline to week 12 | |
Primary | Body composition | It will be evaluated by using the OMROM HBF-514C® 50 Hz portable electrical bioimpedance bascule Change from baseline to week 12 | Change from baseline to week 12 | |
Primary | Anthropometric measures | It will be evaluated by using the SECA anthropometric tape Change from baseline to week 12 | Change from baseline to week 12 | |
Primary | Dietary intake | It will be evaluated by using the ASA24 software for 24-hour reminder collection by multiple steps.
Change from baseline to week 12 |
Change from baseline to week 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04596956 -
Safety and Efficacy of Sodium Bicarbonate Ringer Injection
|
Phase 4 | |
Recruiting |
NCT05135780 -
The Quality of Life in Children at Social Risk, a Case Series Study Protocol
|
||
Not yet recruiting |
NCT04326114 -
Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19
|
N/A | |
Completed |
NCT06341348 -
Effects of Case Management for Patients With Rheumatoid Arthritis in Taiwan
|
N/A | |
Completed |
NCT04379258 -
Analysis of Mortality of Critically Ill Patients With COVID-19
|
||
Not yet recruiting |
NCT05177666 -
a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors
|
||
Completed |
NCT04897919 -
Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria
|
Phase 4 | |
Recruiting |
NCT05617859 -
Lenvatinib for Advanced Bone and Soft Tissue Sarcoma
|
Phase 2 |